Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
4D pharma plc
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Willing and able to sign the consent form
Suspected or confirmed COVID-19 as defined by:
1. Positive RNA test for SARS-CoV-2 OR
2. Presenting with symptoms of COVID-19 as determined by the investigator, and
3. A score of 4 or 5 on the WHO Ordinal Scale for Clinical Improvement, and
4. Oxygen saturation of \<95% on room air, and
5. Chest X-ray with evidence of COVID-19 e.g. ground-glass opacities
Requires admission to hospital
Able to swallow oral capsules
You may not be if
Known valvular heart defects, pulmonary hypertension or heart failure
Known to have cystic fibrosis
GI fistula or malabsorption syndrome
Known allergy to ampicillin, clindamycin and imipenem
Any other condition which, in the opinion of the investigator, would prevent full participation in the study or would interfere with the evaluation of the study endpoints
Antibiotic treatment at enrolment or within 2 days prior
Pregnant or breastfeeding females
Unable or unwilling to follow contraception requirements
Concurrent participation in another interventional clinical trial at enrolment or within 30 days prior
